Literature DB >> 23622368

Autoimmune myasthenia gravis.

Sandeep Jayawant1, Jeremy Parr, Angela Vincent.   

Abstract

Myasthenia gravis in children can be generalized or ocular, and associated with antibodies to acetylcholine receptors or muscle-specific kinase, but it can be negative for those antibodies (seronegative). It needs to be distinguished from congenital myasthenic syndromes and other neuromuscular diseases. In the perinatal period, transient neonatal myasthenia and arthrogryposis multiplex congenita, due to maternal antibodies, need to be considered. Juvenile myasthenia is similar in presentation and treatment to that in adults. Here we present guidelines for recognition, diagnosis, and treatment.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23622368     DOI: 10.1016/B978-0-444-59565-2.00015-0

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

Review 1.  Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.

Authors:  Jeffrey T Guptill; Madhu Soni; Matthew N Meriggioli
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Sniffing out a hidden cause of breathlessness.

Authors:  Alexandra Marie Nanzer; John Janssen; Matthew Hind
Journal:  BMJ Case Rep       Date:  2014-06-27

3.  Dental follicle mesenchymal stem cell administration ameliorates muscle weakness in MuSK-immunized mice.

Authors:  Canan Ulusoy; Noushin Zibandeh; Selin Yıldırım; Nikolaos Trakas; Paraskevi Zisimopoulou; Melike Küçükerden; Hatice Tașlı; Socrates Tzartos; Kamil Göker; Erdem Tüzün; Tunç Akkoç
Journal:  J Neuroinflammation       Date:  2015-12-09       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.